Lv41
500 积分 2026-10-16 加入
Hypogammaglobulinemia After Chimeric Antigen Receptor (CAR) T-Cell Therapy: Characteristics, Management, and Future Directions
8小时前
已完结
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
8小时前
已完结
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial
10小时前
已完结
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
10小时前
已完结
Design and Preclinical Development of a Novel In Vivo Chimeric Antigen Receptor (CAR) Product for B-Cell Involved Diseases
10小时前
已关闭
Barriers to CAR T-cell therapy in rheumatology
10小时前
已完结
First-in-human study of in vivo CAR-T therapy GT801 in adults with relapsed or refractory CD19-positive B-cell hematologic malignancies
3天前
已完结
皖公网安备34019202002308
